Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Related Posts

Osisko Metals Gaspé Copper Project Intersects 645 Metres...

July 22, 2025

Juggernaut Exploration: Advancing High-grade Precious Metals Assets in...

June 12, 2025

Brunswick Exploration Announces Brokered Private Placement for Gross...

May 9, 2025

Crypto Market Recap: Bitcoin Soars Past US$94,000, Beats...

April 24, 2025

Rob McEwen: Gold to Go “Much Higher,” Mining...

July 19, 2025

Metals Focus: Gold to Average US$4,560 in 2026...

October 28, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (257)
    • Investing (1,578)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved